National

Sentence delay for former soldier who planned attack on Veterans Affairs office

Darpan News Desk The Canadian Press, 30 Jan, 2015 10:39 AM

CALGARY — Sentencing for a former Canadian soldier who admitted to planning an attack on the Calgary office of Veterans Affairs has been delayed.

Glen Gieschen (GEE'-shin) had a beef with the department over coverage for illnesses he believed were caused by a flu shot.

The Crown requested a delay until Feb. 11 to review Gieschen's psychiatric assessment.

His lawyer says he was anxious to receive his punishment and put the matter behind him.

The 45-year-old former military intelligence officer pleaded guilty in November to weapons charges.

Police recovered firearms, body armour, possible bomb-making materials, schematics of the downtown skyscraper and a plan to attack the seventh-floor offices of Veterans Affairs.

Prev Next

MORE National ARTICLES

RCMP Make Third Terror-related Arrest Following Charges Against Twins

OTTAWA — The RCMP have arrested a third Ottawa man in an alleged terrorist conspiracy.

RCMP Make Third Terror-related Arrest Following Charges Against Twins

Hockey legend Guy Lafleur suing Quebec Crown and Montreal police for $2 million

MONTREAL — Former Canadiens superstar Guy Lafleur is seeking more than $2 million from the Crown and Montreal police in legal proceedings that began today.

Hockey legend Guy Lafleur suing Quebec Crown and Montreal police for $2 million

Three Ice Climbers Found Dead North Of Whistler: Police

RCMP say the bodies of the two women and a man were discovered in a crevasse about 300 metres below Joffre Peak.

Three Ice Climbers Found Dead North Of Whistler: Police

Perjury case against RCMP related to Dziekanski's death can proceed: B.C. judge

VANCOUVER — A judge has rejected an RCMP officer's attempt to have a perjury case thrown out related to the inquiry into the death of Robert Dziekanski.

Perjury case against RCMP related to Dziekanski's death can proceed: B.C. judge

Tekmira stock soars on plan for merger with OnCore to focus on hepatitis B drugs

VANCOUVER — Shares in Tekmira Pharmaceuticals (TSX:TKM) jumped 40 per cent Monday following a friendly merger proposal with OnCore Biopharma Inc., a U.S. drug developer working on complementary products for treating hepatitis B.

Tekmira stock soars on plan for merger with OnCore to focus on hepatitis B drugs

Lululemon raises Q4 estimates, shares rise to highest since late 2013

VANCOUVER — Lululemon Athletica Inc. (NASDAQ:LULU) says it's more optimistic about the revenue and profit that the clothing company will generate in the current quarter, which includes the Christmas-New Years period.